CAS Number5633-20-5
Synonymscyclohexyl(hydroxy)phénylacétate de 4-(diéthylamino)but-2-yn-1-yle; Cystrin; Oxybutyninum; EINECS 202-516-5; 4-(Diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate; Oxybutynine; benzeneacetic acid, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester; a-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester; a-Cyclohexyl-a-hydroxybenzene acetic acid 4-(diethylamino)-2-butynyl ester; Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester; Oxybutynin Base; 4-(Diethylamino)but-2-in-1-ylcyclohexyl(hydroxy)phenylacetat; 4-Diethylamino-2-butynyl phenyl cyclohexylglycolate; MFCD00865252; Oxybutinin; Lyrinel XL; 4-(Diethylamino)-2-butyn-1-yl cyclohexyl(hydroxy)phenylacetate; Pollakisu; 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacet
Molecular FormulaC22H31O3N1
Molecular Weight357.49
Purity99%
Density1.1±0.1 g/cm3
Boiling Point494.4±45.0 °C at 760 mmHg
Melting Point125 - 130ºC
AppearanceWhite to off-white crystalline powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 5633-20-5 |
| Catalog No. | 2A-9011831 |
| Chinese Name | 奥昔布宁 |
| Synonyms | cyclohexyl(hydroxy)phénylacétate de 4-(diéthylamino)but-2-yn-1-yle; Cystrin; Oxybutyninum; EINECS 202-516-5; 4-(Diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate; Oxybutynine; benzeneacetic acid, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester; a-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester; a-Cyclohexyl-a-hydroxybenzene acetic acid 4-(diethylamino)-2-butynyl ester; Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester; Oxybutynin Base; 4-(Diethylamino)but-2-in-1-ylcyclohexyl(hydroxy)phenylacetat; 4-Diethylamino-2-butynyl phenyl cyclohexylglycolate; MFCD00865252; Oxybutinin; Lyrinel XL; 4-(Diethylamino)-2-butyn-1-yl cyclohexyl(hydroxy)phenylacetate; Pollakisu; 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacet |
| Molecular Formula | C22H31O3N1 |
| Molecular Weight | 357.49 |
| Purity | 99 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 494.4±45.0 °C at 760 mmHg |
| Melting Point | 125 - 130ºC |
| Appearance | White to off-white crystalline powder |
| Storage Condition | -20°C |
| Application | Oxybutynin is an anticholinergic drug that can relieve difficulty urinating. |
| HTC | 2922509090 |
| MDL Number | MFCD00865252 |
| SMILES | CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1 |
| InChI | InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3 |
| InChI Key | XIQVNETUBQGFHX-UHFFFAOYSA-N |
| MSDS | msds/11831_1_5633_20_5.pdf |
| Bioactivity | Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties.Target: mAChROxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. Oxybutynin competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic, but at concentrations far above those used clinically. Oxybutynin is available orally in generic formulation or as the brand-names Ditropan, Lyrinel XL, or Ditrospam, as a transdermal patch under the brand name Oxytrol, and as a topical gel under the brand name Gelnique. Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) [1-3]. Related Catalog Signaling Pathways >> GPCR/G Protein >> mAChR Signaling Pathways >> Neuronal Signaling >> mAChR Research Areas >> Neurological Disease References [1]. Tupker, R.A., A.M. Harmsze, and V.H. Deneer, Oxybutynin therapy for generalized hyperhidrosis. Archives of dermatology, 2006. 142(8): p. 1065-1086. [2]. Mijnhout, G., et al., Oxybutynin: dry days for patients with hyperhidrosis. Neth J Med, 2006. 64(9): p. 326-8. [3]. Schollhammer, M. and L. Misery, Treatment of hyperhidrosis with oxybutynin. Archives of dermatology, 2007. 143(4): p. 543-551. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 494.4±45.0 °C at 760 mmHg Melting Point 125 - 130ºC Molecular Formula C22H31NO3 Molecular Weight 357.486 Flash Point 252.8±28.7 °C Exact Mass 357.230408 PSA 49.77000 LogP 5.19 Vapour Pressure 0.0±1.3 mmHg at 25°C Index of Refraction 1.546 InChIKey XIQVNETUBQGFHX-UHFFFAOYSA-N SMILES CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1 Storage condition -20°C |
| Use of | Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties.Target: mAChROxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. Oxybutynin competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic, but at concentrations far above those used clinically. Oxybutynin is available orally in generic formulation or as the brand-names Ditropan, Lyrinel XL, or Ditrospam, as a transdermal patch under the brand name Oxytrol, and as a topical gel under the brand name Gelnique. Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) [1-3]. Properties Name oxybutynin Synonym More Synonyms oxybutynin Biological Activity Description Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties.Target: mAChROxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. Oxybutynin competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic, but at concentrations far above those used clinically. Oxybutynin is available orally in generic formulation or as the brand-names Ditropan, Lyrinel XL, or Ditrospam, as a transdermal patch under the brand name Oxytrol, and as a topical gel under the brand name Gelnique. Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) [1-3]. Related Catalog Signaling Pathways >> GPCR/G Protein >> mAChR Signaling Pathways >> Neuronal Signaling >> mAChR Research Areas >> Neurological Disease References [1]. Tupker, R.A., A.M. Harmsze, and V.H. Deneer, Oxybutynin therapy for generalized hyperhidrosis. Archives of dermatology, 2006. 142(8): p. 1065-1086. [2]. Mijnhout, G., et al., Oxybutynin: dry days for patients with hyperhidrosis. Neth J Med, 2006. 64(9): p. 326-8. [3]. Schollhammer, M. and L. Misery, Treatment of hyperhidrosis with oxybutynin. Archives of dermatology, 2007. 143(4): p. 543-551. Chemical & Physical Properties Molecular Formula C22H31NO3 Exact Mass 357.230408 PSA 49.77000 Index of Refraction 1.546 InChIKey XIQVNETUBQGFHX-UHFFFAOYSA-N |
| Tax Rebate | 13.0% |
| Supervision | A. Customs clearance form for inbound goods B. Customs clearance form for outbound goods |
| Inspection | R. Hygiene supervision and inspection of imported food S. Hygiene supervision and inspection of exported food |
| Transport Info | Product name: Supervision conditions A. Customs clearance form for inbound goods B. Customs clearance form for outbound goods |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Oxolamine | 959-14-8 | 2A-9011826 |
| Oxomemazine | 3689-50-7 | 2A-9011827 |
| Oxonazine | 5580-22-3 | 2A-9011828 |
| Oxprenolol | 6452-71-7 | 2A-9011829 |
| Oxprenolol Hydrochloride | 6452-73-9 | 2A-9011830 |
| Oxybutynin hydrochloride | 1508-65-2 | 2A-9011832 |
| Oxychlordane | 27304-13-8 | 2A-9011833 |
| Oxychlorosene | 8031-14-9 | 2A-9011834 |
| Oxyclozanide | 2277-92-1 | 2A-0202371 |
| Oxydimethin | 55290-64-7 | 2A-9011836 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS